| Year |
Citation |
Score |
| 2011 |
Gautam AH, Zeevalk GD. Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities. Biochimica Et Biophysica Acta. 1807: 819-28. PMID 21463600 DOI: 10.1016/J.Bbabio.2011.03.013 |
0.635 |
|
| 2010 |
Zeevalk GD, Bernard LP, Guilford FT. Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells. Neurochemical Research. 35: 1575-87. PMID 20535554 DOI: 10.1007/s11064-010-0217-0 |
0.357 |
|
| 2009 |
Neal-Perry G, Lebesgue D, Lederman M, Shu J, Zeevalk GD, Etgen AM. The excitatory peptide kisspeptin restores the luteinizing hormone surge and modulates amino acid neurotransmission in the medial preoptic area of middle-aged rats. Endocrinology. 150: 3699-708. PMID 19423763 DOI: 10.1210/En.2008-1667 |
0.308 |
|
| 2008 |
Neal-Perry GS, Zeevalk GD, Shu J, Etgen AM. Restoration of the luteinizing hormone surge in middle-aged female rats by altering the balance of GABA and glutamate transmission in the medial preoptic area. Biology of Reproduction. 79: 878-88. PMID 18667749 DOI: 10.1095/Biolreprod.108.069831 |
0.304 |
|
| 2008 |
Zeevalk GD, Razmpour R, Bernard LP. Glutathione and Parkinson's disease: is this the elephant in the room? Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 62: 236-49. PMID 18400456 DOI: 10.1016/J.Biopha.2008.01.017 |
0.377 |
|
| 2008 |
Zeevalk GD, Ehrhart J. Functional glutaredoxin activity in rat brain & liver mitochondria Journal of Neurochemistry. 81: 45-45. DOI: 10.1046/J.1471-4159.81.S1.14_3.X |
0.626 |
|
| 2007 |
Domico LM, Cooper KR, Bernard LP, Zeevalk GD. Reactive oxygen species generation by the ethylene-bis-dithiocarbamate (EBDC) fungicide mancozeb and its contribution to neuronal toxicity in mesencephalic cells. Neurotoxicology. 28: 1079-91. PMID 17597214 DOI: 10.1016/J.Neuro.2007.04.008 |
0.681 |
|
| 2007 |
Zeevalk GD, Manzino L, Sonsalla PK, Bernard LP. Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease Experimental Neurology. 203: 512-520. PMID 17049515 DOI: 10.1016/j.expneurol.2006.09.004 |
0.394 |
|
| 2006 |
Domico LM, Zeevalk GD, Bernard LP, Cooper KR. Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction. Neurotoxicology. 27: 816-25. PMID 16889834 DOI: 10.1016/J.Neuro.2006.07.009 |
0.698 |
|
| 2006 |
Yazdani U, German DC, Liang CL, Manzino L, Sonsalla PK, Zeevalk GD. Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+). Experimental Neurology. 200: 172-83. PMID 16546169 DOI: 10.1016/j.expneurol.2006.02.002 |
0.326 |
|
| 2006 |
ZEEVALK GD, BERNARD LP, EHRHART J. Glutathione and Ascorbate Annals of the New York Academy of Sciences. 991: 342-345. DOI: 10.1111/J.1749-6632.2003.TB07501.X |
0.601 |
|
| 2005 |
Zeevalk GD, Bernard LP, Song C, Gluck M, Ehrhart J. Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration. Antioxidants & Redox Signaling. 7: 1117-39. PMID 16115016 DOI: 10.1089/Ars.2005.7.1117 |
0.69 |
|
| 2005 |
Zeevalk GD, Bernard LP. Energy status, ubiquitin proteasomal function, and oxidative stress during chronic and acute complex I inhibition with rotenone in mesencephalic cultures. Antioxidants & Redox Signaling. 7: 662-72. PMID 15890011 DOI: 10.1089/Ars.2005.7.662 |
0.515 |
|
| 2004 |
Gluck MR, Zeevalk GD. Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases. Journal of Neurochemistry. 91: 788-95. PMID 15525332 DOI: 10.1111/J.1471-4159.2004.02747.X |
0.449 |
|
| 2003 |
Alfinito PD, Wang SP, Manzino L, Rijhsinghani S, Zeevalk GD, Sonsalla PK. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10982-7. PMID 14645494 DOI: 10.1523/Jneurosci.23-34-10982.2003 |
0.475 |
|
| 2003 |
Ehrhart J, Zeevalk GD. Cooperative interaction between ascorbate and glutathione during mitochondrial impairment in mesencephalic cultures. Journal of Neurochemistry. 86: 1487-97. PMID 12950457 DOI: 10.1046/J.1471-4159.2003.01954.X |
0.723 |
|
| 2003 |
Zeevalk GD, Bernard LP, Ehrhart J. Glutathione and ascorbate: Their role in protein glutathione mixed disulfide formation during oxidative stress and potential relevance to Parkinson's disease Annals of the New York Academy of Sciences. 991: 342-345. |
0.603 |
|
| 2002 |
Ehrhart J, Gluck M, Mieyal J, Zeevalk GD. Functional glutaredoxin (thioltransferase) activity in rat brain and liver mitochondria. Parkinsonism & Related Disorders. 8: 395-400. PMID 12217626 DOI: 10.1016/S1353-8020(02)00020-2 |
0.619 |
|
| 2002 |
Zeevalk GD, Manzino L, Sonsalla PK. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum. Experimental Neurology. 176: 193-202. PMID 12093096 DOI: 10.1006/Exnr.2002.7917 |
0.395 |
|
| 2002 |
Gluck M, Ehrhart J, Jayatilleke E, Zeevalk GD. Inhibition of brain mitochondrial respiration by dopamine: involvement of H(2)O(2) and hydroxyl radicals but not glutathione-protein-mixed disulfides. Journal of Neurochemistry. 82: 66-74. PMID 12091466 DOI: 10.1046/j.1471-4159.2002.00938.x |
0.71 |
|
| 2001 |
Zeevalk GD, Bernard LP, Manzino L, Sonsalla PK. Differential sensitivity of mesencephalic neurons to inhibition of phosphatase 2A Journal of Pharmacology and Experimental Therapeutics. 298: 925-933. PMID 11504786 |
0.335 |
|
| 2001 |
Ehrhart J, Zeevalk GD. Hydrogen peroxide removal and glutathione mixed disulfide formation during metabolic inhibition in mesencephalic cultures. Journal of Neurochemistry. 77: 1496-507. PMID 11413233 DOI: 10.1046/j.1471-4159.2001.00355.x |
0.715 |
|
| 2000 |
Zeevalk GD, Nicklas WJ. Lactate prevents the alterations in tissue amino acids, decline in ATP, and cell damage due to aglycemia in retina Journal of Neurochemistry. 75: 1027-1034. PMID 10936183 DOI: 10.1046/J.1471-4159.2000.0751027.X |
0.342 |
|
| 2000 |
Moy LY, Zeevalk GD, Sonsalla PK. Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures. Journal of Neurochemistry. 74: 1656-65. PMID 10737624 DOI: 10.1046/J.1471-4159.2000.0741656.X |
0.54 |
|
| 2000 |
Zeevalk GD, Manzino L, Sonsalla PK. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum Experimental Neurology. 161: 638-646. PMID 10686083 DOI: 10.1006/Exnr.1999.7283 |
0.431 |
|
| 2000 |
Zeevalk GD, Bernard LP, Nicklas WJ. Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity Neuroscience. 96: 309-316. PMID 10683571 DOI: 10.1016/S0306-4522(99)00567-9 |
0.472 |
|
| 1998 |
Sonsalla PK, Albers DS, Zeevalk GD. Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism Amino Acids. 14: 69-74. PMID 9871444 DOI: 10.1007/Bf01345245 |
0.442 |
|
| 1998 |
Zeevalk GD, Davis N, Hyndman AG, Nicklas WJ. Origins of the extracellular glutamate released during total metabolic blockade in the immature retina Journal of Neurochemistry. 71: 2373-2381. PMID 9832135 DOI: 10.1046/J.1471-4159.1998.71062373.X |
0.338 |
|
| 1998 |
Zeevalk GD, Bernard LP, Sinha C, Ehrhart J, Nicklas WJ. Excitotoxicity and oxidative stress during inhibition of energy metabolism. Developmental Neuroscience. 20: 444-53. PMID 9778583 DOI: 10.1159/000017342 |
0.711 |
|
| 1998 |
Zeevalk GD, Bernard LP, Nicklas WJ. Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism Journal of Neurochemistry. 70: 1421-1430. PMID 9523558 |
0.455 |
|
| 1997 |
Zeevalk GD, Nicklas WJ. Activity at the GABA transporter contributes to acute cellular swelling produced by metabolic impairment in retina Vision Research. 37: 3463-3470. PMID 9425523 DOI: 10.1016/S0042-6989(97)00184-3 |
0.367 |
|
| 1997 |
Sonsalla PK, Manzino L, Sinton CM, Liang CL, German DC, Zeevalk GD. Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra. Brain Research. 773: 223-6. PMID 9409726 DOI: 10.1016/S0006-8993(97)00941-4 |
0.309 |
|
| 1997 |
Zeevalk GD, Nicklas WJ. Contribution of glial metabolism to neuronal damage caused by partial inhibition of energy metabolism in retina Experimental Eye Research. 65: 397-405. PMID 9299176 DOI: 10.1006/Exer.1997.0347 |
0.41 |
|
| 1997 |
Zeevalk GD, Manzino L, Hoppe J, Sonsalla P. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism European Journal of Pharmacology. 320: 111-119. PMID 9059843 DOI: 10.1016/S0014-2999(96)00892-8 |
0.467 |
|
| 1997 |
Zeevalk GD, Bernard LP, Albers DS, Mirochnitchenko O, Nicklas WJ, Sonsalla PK. Energy stress-induced dopamine loss in glutathione peroxidase- overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures Journal of Neurochemistry. 68: 426-429. PMID 8978755 DOI: 10.1046/J.1471-4159.1997.68010426.X |
0.482 |
|
| 1996 |
Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Research. 738: 172-5. PMID 8949944 DOI: 10.1016/0006-8993(96)00995-X |
0.333 |
|
| 1996 |
Zeevalk GD, Nicklas WJ. Attenuation of excitotoxic cell swelling and GABA release by the GABA transport inhibitor SKF 89976A Molecular and Chemical Neuropathology. 29: 27-36. PMID 8887938 DOI: 10.1007/Bf02815191 |
0.327 |
|
| 1996 |
Albers DS, Zeevalk GD, Sonsalla PK. Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP Brain Research. 718: 217-220. PMID 8773791 DOI: 10.1016/0006-8993(96)00135-7 |
0.44 |
|
| 1995 |
Zeevalk GD, Derr-Yellin E, Nicklas WJ. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3- nitropropionic acid and protection by NMDA receptor blockade Journal of Pharmacology and Experimental Therapeutics. 275: 1124-1130. PMID 8531072 |
0.346 |
|
| 1995 |
Zeevalk GD, Derr‐Yellin E, Nicklas WJ. NMDA Receptor Involvement in Toxicity to Dopamine Neurons In Vitro Caused by the Succinate Dehydrogenase Inhibitor 3‐Nitropropionic Acid Journal of Neurochemistry. 64: 455-458. PMID 7798946 DOI: 10.1046/J.1471-4159.1995.64010455.X |
0.475 |
|
| 1995 |
Zeevalk GD, Schoepp D, Nicklas WJ. Excitotoxicity at both NMDA and non-NMDA glutamate receptors is antagonized by aurintricarboxylic acid: Evidence for differing mechanisms of action Journal of Neurochemistry. 64: 749-758. DOI: 10.1046/J.1471-4159.1995.64041749.X |
0.308 |
|
| 1993 |
Zeevalk GD, Schoepp D, Nicklas WJ. Aurintricarboxylic acid prevents NMDA-mediated excitotoxicity: Evidence for its action as an NMDA receptor antagonist Journal of Neurochemistry. 61: 386-389. PMID 8390567 DOI: 10.1111/J.1471-4159.1993.Tb03585.X |
0.307 |
|
| 1992 |
Zeevalk GD, Nicklas WJ. Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism Journal of Neurochemistry. 59: 1211-1220. PMID 1402878 DOI: 10.1111/J.1471-4159.1992.Tb08430.X |
0.327 |
|
| 1989 |
Zeevalk GD, Hyndman AG, Nicklas WJ. Excitatory Amino Acid‐Induced Toxicity in Chick Retina: Amino Acid Release, Histology, and Effects of Chloride Channel Blockers Journal of Neurochemistry. 53: 1610-1619. PMID 2477502 DOI: 10.1111/J.1471-4159.1989.Tb08559.X |
0.316 |
|
| Show low-probability matches. |